Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Roth

Showing results (601-610 of 638) with videos related to

Pageof 64
Sort By:
Annals of Surgical Oncology|December 30, 1998
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]M Bouvet, R J Bold, J Lee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2001
Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vectorR Ramesh, T Saeki, N S Templeton, et al.
Molecular and Cellular Biology|June 1, 1995
Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expressionL B Owen-Schaub, W Zhang, J C Cusack, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 6, 2000
Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancerS G Swisher, L Deford, K W Merriman, et al.
Cancer|July 15, 1989
Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experienceM Shiraki, H T Enterline, J J Brooks, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 1995
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancerR Komaki, D M Shin, B S Glisson, et al.
Cancer Research|July 15, 1991
Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trialS C Yang, E A Grimm, D R Parkinson, et al.
Lung Cancer (Amsterdam, Netherlands)|October 29, 1998
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancerJ A Roth, E N Atkinson, F Fossella, et al.
The Annals of Thoracic Surgery|January 22, 1998
Anterior approaches to the thoracic spine in patients with cancer: indications and resultsG L Walsh, Z L Gokaslan, I E McCutcheon, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1996
Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight casesP M Schneider, A G Casson, B Levin, et al.
Pageof 64

Showing results (601-610 of 638) with videos related to

Sort By:
Pageof 64
Annals of Surgical Oncology|December 30, 1998
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]M Bouvet, R J Bold, J Lee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2001
Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vectorR Ramesh, T Saeki, N S Templeton, et al.
Molecular and Cellular Biology|June 1, 1995
Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expressionL B Owen-Schaub, W Zhang, J C Cusack, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 6, 2000
Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancerS G Swisher, L Deford, K W Merriman, et al.
Cancer|July 15, 1989
Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experienceM Shiraki, H T Enterline, J J Brooks, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 1995
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancerR Komaki, D M Shin, B S Glisson, et al.
Cancer Research|July 15, 1991
Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trialS C Yang, E A Grimm, D R Parkinson, et al.
Lung Cancer (Amsterdam, Netherlands)|October 29, 1998
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancerJ A Roth, E N Atkinson, F Fossella, et al.
The Annals of Thoracic Surgery|January 22, 1998
Anterior approaches to the thoracic spine in patients with cancer: indications and resultsG L Walsh, Z L Gokaslan, I E McCutcheon, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1996
Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight casesP M Schneider, A G Casson, B Levin, et al.
Pageof 64